Laxmi Dental Ltd
Incorporated in 2004, Laxmi Dental is an integrated dental products company offering a comprehensive portfolio of Dental Products[1]
- Market Cap ₹ 1,742 Cr.
- Current Price ₹ 317
- High / Low ₹ 584 / 302
- Stock P/E 92.5
- Book Value ₹ 40.5
- Dividend Yield 0.00 %
- ROCE 17.3 %
- ROE 14.6 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 51.2% CAGR over last 5 years
Cons
- Stock is trading at 7.82 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 8.77% over past five years.
- Earnings include an other income of Rs.11.0 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies
Part of BSE Healthcare BSE SmallCap BSE IPO BSE Allcap
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
---|---|---|---|---|---|---|---|
112 | 63 | 113 | 126 | 139 | 171 | 178 | |
110 | 59 | 109 | 119 | 128 | 144 | 150 | |
Operating Profit | 3 | 4 | 4 | 6 | 12 | 27 | 28 |
OPM % | 3% | 7% | 3% | 5% | 8% | 16% | 16% |
1 | 0 | 4 | 8 | 14 | 19 | 11 | |
Interest | 3 | 3 | 3 | 4 | 5 | 4 | 3 |
Depreciation | 6 | 6 | 7 | 9 | 9 | 10 | 10 |
Profit before tax | -5 | -4 | -2 | 1 | 12 | 32 | 26 |
Tax % | 5% | 9% | 118% | 0% | -85% | 18% | |
-5 | -4 | -4 | 1 | 23 | 26 | 19 | |
EPS in Rs | -155.57 | -140.95 | -142.58 | 46.12 | 737.58 | 4.69 | 4.18 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 9% |
3 Years: | 15% |
TTM: | 23% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 51% |
3 Years: | 86% |
TTM: | -11% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 12% |
3 Years: | 21% |
Last Year: | 15% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Equity Capital | 0.31 | 0.31 | 0.31 | 0.31 | 0.31 | 11 |
Reserves | 44 | 40 | 36 | 28 | 51 | 212 |
36 | 36 | 41 | 42 | 53 | 5 | |
28 | 29 | 29 | 37 | 31 | 48 | |
Total Liabilities | 109 | 105 | 106 | 108 | 136 | 276 |
38 | 41 | 32 | 35 | 33 | 40 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | 16 | 16 | 17 | 14 | 14 | 17 |
54 | 48 | 57 | 59 | 89 | 219 | |
Total Assets | 109 | 105 | 106 | 108 | 136 | 276 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
10 | 10 | -4 | 10 | 5 | 47 | |
-15 | -9 | 3 | -6 | -6 | -49 | |
6 | -1 | 1 | -1 | -2 | 104 | |
Net Cash Flow | 0 | 1 | -1 | 3 | -3 | 102 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Debtor Days | 90 | 95 | 73 | 85 | 88 | 68 |
Inventory Days | 189 | 377 | 195 | 162 | 196 | 132 |
Days Payable | 184 | 310 | 147 | 151 | 82 | 196 |
Cash Conversion Cycle | 95 | 162 | 120 | 95 | 201 | 4 |
Working Capital Days | 21 | 9 | 27 | 20 | 71 | 72 |
ROCE % | 0% | 1% | 6% | 19% | 17% |
Documents
Announcements
- Closure of Trading Window 1h
-
Announcement under Regulation 30 (LODR)-Updates on Acquisition
19 Sep - Completed acquisition: 49% equity (₹1.37 crore) and 9% CCPS (₹62.88 lakh) in IDBG on Sep 19, 2025.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
19 Sep - Of Schedule of Analyst / Institutional Investor meetings under the SEBI (LODR), Regulations 2015.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
8 Sep - Completion of dispatch of the Annual Report for the Financial Year ("FY") 2024-2025 including Notice of the 21st Annual General Meeting (AGM)
- Reg. 34 (1) Annual Report. 6 Sep
Concalls
-
Aug 2025Transcript PPT
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Feb 2025TranscriptNotesPPT
Leading Dental Company[1]
Laxmi Dental is the only end-to-end integrated dental products company in India. Based on FY23 revenue & PAT, the company is the largest and most profitable vertically integrated, indigenous B2B2C dental aligner solutions provider.